| Patent application number | Description | Published |
|---|
| 20080213165 | Methods and Compositions for Increasing Patent Tolerability During Myocardial Imaging Methods - The present application discloses methods and compositions for increasing patient tolerability during myocardial imaging comprising the administration of doses of caffeine and one or more adenosine A | 09-04-2008 |
| 20080248112 | USE OF RANOLAZINE FOR THE TREATMENT OF CORONARY MICROVASCULAR DISEASES - Disclosed are methods for treating patients suffering from coronary microvascular disease comprising administering ranolazine to the patient. In one embodiment, ranolazine is administered as an oral dose | 10-09-2008 |
| 20080255031 | METHOD FOR ENHANCING INSULIN SECRETION - The invention is directed to methods for enhancing endogenous insulin levels in a patient in need thereof which method comprises administering to the patient an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine. It is also directed to methods of treatment comprising racemic ranolazine or the R- or S-enantiomer of ranolazine for enhancing endogenous insulin levels in a patient in need thereof. It is also directed to a composition comprising an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine and at least one anti-diabetic agent. | 10-16-2008 |
| 20090081120 | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods - The present application discloses methods and compositions for increasing patient tolerability during myocardial imaging comprising the administration of doses of caffeine and one or more adenosine A | 03-26-2009 |
| 20090118221 | METHOD OF TREATING ARRHYTHMIAS - Methods are provided for treating arrhythmia in a manner that minimizes undesirable side effects, comprising administration of a therapeutically effective minimal dose of an A | 05-07-2009 |
| 20090203689 | ABCA-1 ELEVATING COMPOUNDS AND METHODS - Disclosed are novel compounds of Formula I | 08-13-2009 |
| 20090203707 | METHODS FOR TREATING PAIN - This invention relates to methods for treating a patient suffering from neuropathic or nociceptive pain which may be mechanical, visceral, and/or inflammatory in nature, comprising administering a therapeutically effective amount of Ranolazine to a patient in need thereof. | 08-13-2009 |
| 20090312340 | USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES - Disclosed are methods for treating patients suffering from cardiovascular diseases comprising administering an intravenous (IV) infusion of ranolazine. In one embodiment, the IV infusion of ranolazine is followed by an orally administered sustained release ranolazine dosage formulation to maintain human ranolazine plasma levels at therapeutic levels in patients. | 12-17-2009 |
| 20100004255 | METHOD OF TREATING ARRHYTHMIAS - Methods are provided for treating arrhythmias including tachycardias, such as idiopathic ventricular tachycardia, ventricular fibrillation, and Torsade de Pointes (TdP) in a manner that minimizes undesirable side effects. | 01-07-2010 |
| 20100056536 | METHOD OF TREATING ATRIAL FIBRILLATION - The present invention relates to a method for the treatment of atrial fibrillation comprising the coadministration of a synergistic therapeutically effective amount of amiodarone and synergistic therapeutically effective amount ranolazine. This invention also relates to pharmaceutical formulations that are suitable for such combined administration. | 03-04-2010 |
| 20100086483 | METHOD OF MULTIDETECTOR COMPUTED TOMAGRAPHY - This invention relates to methods for multidetector computed tomography myocardial perfusion imaging comprising administering doses of a rate-control agent and one or more adenosine A | 04-08-2010 |
| 20100105695 | METHOD FOR ENHANCING INSULIN SECRETION - The invention is directed to methods for enhancing endogenous insulin levels in a patient in need thereof which method comprises administering to the patient an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine. It is also directed to methods of treatment comprising racemic ranolazine or the R- or S-enantiomer of ranolazine for enhancing endogenous insulin levels in a patient in need thereof. It is also directed to a composition comprising an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine and at least one anti-diabetic agent. | 04-29-2010 |
| 20100105706 | METHOD OF PREVENTING AND TREATING AIRWAY REMODELING AND PULMONARY INFLAMMATION USING A2B ADENOSINE RECEPTOR ANTAGONISTS - The present invention relates to methods of preventing airway remodeling using A | 04-29-2010 |
| 20100130436 | CO-ADMINISTRATION OF RANOLAZINE AND CARDIAC GLYCOSIDES - The present invention relates to a method for reducing the toxicity of cardiac glycosides comprising the coadministration of a therapeutically effective amount of cardiac glycoside and a therapeutically effective amount ranolazine. This invention also relates to pharmaceutical formulations that are suitable for such combined administration. | 05-27-2010 |
| 20100158797 | USE OF A2A ADENOSINE RECEPTOR AGONISTS - Myocardial imaging methods that are accomplished by administering doses of a pharmaceutical composition including regadenoson—an adenosine A | 06-24-2010 |
| 20100160620 | N-PYRAZOLE A2A RECEPTOR AGONISTS - 2-adenosine N-pyrazole compounds having the following formula: | 06-24-2010 |
| 20100183503 | MYOCARDIAL PERFUSION IMAGING METHODS AND COMPOSITIONS - A myocardial imaging method that is accomplished by administering one or more adenosine A | 07-22-2010 |
| 20100292217 | RANOLAZINE FOR THE TREATMENT OF CNS DISORDERS - The present invention relates to a method for CNS disorders such as epilepsy and migraine comprising the administration of a therapeutically effective amount of ranolazine. | 11-18-2010 |
| 20110144320 | N-PYRAZOLE A2A RECEPTOR AGONISTS - 2-adenosine N-pyrazole compounds having the following formula: | 06-16-2011 |
